FUJIFILM Diosynth Biotechnologies and RoosterBio Announce Collaboration to enable GMP Manufacturing of Cell and Exosome Therapies

URLhttps://www.fujifilm.com/us/en/news/FDB_RoosterBIO
SourceFujifilm
Date Published10/24/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Fujifilm Diosynth Biotechnologies
Parent companyFujifilm Corporation
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2022
Country(ies) from which reshored:Japan
City reshored to:College Station
State(s) reshored to:TX
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshored biologics, vaccines, advanced therapies
What domestic positive factors made reshoring more attractive?Skilled workforce availability/training
Find Reshoring Articles